Chapter 9: Confusion in Older Adults Assessment
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Confusion in Older Adults Assessment emphasizes that confusion is not a disease state itself but a manifestation of underlying pathology, often exacerbated by the physiological changes of aging and polypharmacy. The summary details the characteristics of delirium as a medical emergency defined by an acute onset, fluctuating course, and altered level of consciousness, often triggered by systemic issues like infection, electrolyte imbalance, or medication toxicity. In contrast, the chapter explores dementia as a chronic, insidious, and progressive decline in intellectual function—affecting memory, language (aphasia), and visuospatial skills—where the patient typically remains alert. It categorizes dementia causes into reversible factors (such as Vitamin B12 deficiency or thyroid dysfunction), modifiable conditions, and irreversible diseases like Alzheimer disease, multi-infarct (vascular) dementia, Dementia with Lewy bodies, and frontotemporal degeneration. Depression is analyzed as a potential mimic of dementia (pseudodementia), characterized by a sub-acute onset, vegetative symptoms, and patients who are often keenly aware of and verbal about their cognitive deficits. The text outlines a rigorous diagnostic reasoning process, stressing the importance of collateral history to establish baseline function and the use of validated screening tools such as the Confusion Assessment Method (CAM) for delirium, the Mini-Cog or Montreal Cognitive Assessment (MoCA) for cognitive impairment, and the Geriatric Depression Scale (GDS) or PHQ-9 for mood disorders. Furthermore, it describes critical physical and neurological examination findings, such as asterixis (liver flap), parkinsonian signs (tremor, rigidity), or focal neurologic deficits that point to cerebrovascular events. Finally, the summary covers the essential diagnostic workup, including laboratory panels to rule out metabolic or infectious causes and the utility of neuroimaging (CT, MRI, PET) to visualize structural brain changes or confirm specific dementia subtypes.